Interview 18 Nov 2022 How cardioids can usher in the next generation of drug discovery The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s cardioid technology to enable unique and scalable drug discovery and cardiac safety testing. Cardiovascular diseases are the leading cause of death worldwide, claiming an estimated 17.9 million lives each year. Despite this, the cardiovascular therapeutics market has lagged behind the […] November 18, 2022 - 6 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Nov 2022 Get to know 15 of the best biotech companies in Paris Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15 interesting biotech companies in Paris. Paris is one of the biggest biotech clusters in Europe, with a wide range of applications being developed from drug discovery and medical devices to synthetic biology and green energy. […] November 4, 2022 - 11 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Interview 28 Oct 2022 Migraines: a new vaccine frontier beyond infectious diseases By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S. company Vaxxinity aims to open a new frontier for vaccines in an effort to reach all patient populations, regardless of location or income. Migraine causes severe headaches that are characterized by throbbing pain and associated symptoms such as sensitivity to […] October 28, 2022 - 7 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Interview 27 Sep 2022 Europe’s first lab-grown fish company Bluu Seafood is aiming for sustainability Overfishing is a global issue that negatively impacts the ecosystem and our access to fish protein. One solution to overfishing is producing fish products in the lab from harvested animal cells. This can help feed the world while using up fewer resources and without endangering wild fish populations. As the world’s population continues to grow, […] September 27, 2022 - 5 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Aug 2022 Five cleantech companies making New Zealand more green Cleantechs are focused on reducing negative environmental impacts by offering recycling, renewable energy, green chemistry solutions and more. From extracting gold from old electronics to seaweed supplements for cattle, here are five cleantech companies hailing from New Zealand. New Zealand has been ranked fourth in the world for biotechnology innovation potential. By leveraging the country’s […] August 25, 2022 - 4 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Interview 19 Aug 2022 How re-engineering antibodies can prevent allergies The California startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies that can block this response. We spoke with IgGenix’s CEO Jessica Grossman and CTO Derek Croote to understand the potential of such a therapy. Allergies are overreactions of the immune system to foreign substances that are normally harmless. Worldwide, and […] August 19, 2022 - 9 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Aug 2022 Five emerging biotech hubs in the Asia-Pacific region The Asia-Pacific (APAC) region is the third largest pharmaceutical market in the world, and has seen a shift from predominantly producing generics to developing innovative technologies. Here are five emerging biotech hubs in the region to keep an eye on. The life sciences industry is seeing rapid growth in the APAC region – home to […] August 19, 2022 - 7 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jul 2022 Five companies personalizing treatments with 3D printed drugs There has been a noticeable shift in recent years towards the personalization of medicine, with the pharmaceutical industry showing interest in pills that are tailored to a patient’s needs. Here are five companies that are leveraging 3D printing to produce customizable drugs. Conventional drug production relies on large-scale batch manufacturing, which is very efficient at […] July 28, 2022 - 5 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
In Depth 26 Jul 2022 How DNA sequencing can safeguard against biodiversity loss Preserving Earth’s biodiversity is crucial as we rely on healthy ecosystems for many services, from clean air and water to protection from floods and pandemics. DNA sequencing is an invaluable tool for characterizing biodiversity and informing conservation efforts. In Earth’s history, there have been five major mass extinction events — the most recent of which […] July 26, 2022 - 8 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jul 2022 Triastek forms pact with Eli Lilly to 3D print tablets for oral drug delivery A new research collaboration between Triastek, Inc. and Eli Lilly and Company will leverage 3D printing technology to achieve precise targeting and programmed drug release in the intestine. The China-based Triastek has developed proprietary 3D printing technology that provides solutions for drug development. According to the agreement, Triastek and Lilly will focus on improving the […] July 15, 2022 - 3 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jul 2022 WHO and UNICEF sound the alarm as global vaccination coverage continues to decline Amid worldwide disruptions caused by the COVID-19 pandemic, WHO and UNICEF report the largest continued backslide in childhood vaccinations in approximately three decades, with 25 million infants missing out on lifesaving vaccines in 2021 alone. It was hoped that the cohort of children that missed their vaccinations in 2020 would be caught up in 2021, […] July 15, 2022 - 4 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2022 GenScript ProBio enters strategic partnerships with two South Korean biotechs GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU) with DAAN Bio Therapeutics for the discovery and development of novel drugs and with ACT Therapeutics to develop new CAR-T cell therapies. With offices located in the U.S., the Netherlands, China, Singapore and Japan, GenScript […] July 14, 2022 - 3 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email